Fibronectin inhibits cytokine production induced by CpG DNA in macrophages without direct binding to DNA

Cytokine

Volumn 60, Issue 1, 2012, Pages 162-170

  Yoshida, Hiroyuki ^a   Nishikawa, Makiya ^a   Yasuda, Sachiyo ^a   Toyota, Hiroyasu ^a   Kiyota, Tsuyoshi ^a   Takahashi, Yuki ^a   Takakura, Yoshinobu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

CpG DNA; DNA binding domain; Fibronectin; Inflammatory cytokine; Macrophages

Indexed keywords

BOVINE SERUM ALBUMIN; COLLAGEN; CPG OLIGODEOXYNUCLEOTIDE; DIVALENT CATION; FIBRONECTIN; IMIQUIMOD; LAMININ; LIPOPOLYSACCHARIDE; PLASMID DNA; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; ELECTROPHORESIS; ENDOSOME; LYSOSOME; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

AMINOQUINOLINES; ANIMALS; ANTIBODIES, BLOCKING; CATIONS, DIVALENT; CELL LINE; CELLS, CULTURED; CYTOKINES; ENDOSOMES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRONECTINS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA5BETA1; INTERFERON INDUCERS; LYSOSOMES; MACROPHAGES; MALE; MICE; MICE, INBRED C3H; MICE, INBRED ICR; MICROSCOPY, CONFOCAL; OLIGODEOXYRIBONUCLEOTIDES; POLY I-C; PROTEIN BINDING; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE;

EID: 84865439661     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.06.237     Document Type: Article

References (41)

1. Romberger D.J. Fibronectin. Int J Biochem Cell Biol. 1997, 29:939-943.
2. Ruoslahti E., Engvall E., Hayman E.G. Fibronectin: current concepts of its structure and functions. Collagen Rel Res 1981, 1:95-128.
3. Schwarzbauer J.E. Fibronectin: from gene to protein. Curr Opin Cell Biol 1991, 3:786-791.
4. Hershkoviz R., Alon R., Gilat D., Lider O. Activated T lymphocytes and macrophages secrete fibronectin which strongly supports cell adhesion. Cell Immunol 1992, 141:352-361.
5. Okamura Y., Watari M., Jerud E.S., Young D.W., Ishizaka S.T., Rose J., et al. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 2001, 276:10229-10233.
6. Gondokaryono S.P., Ushio H., Niyonsaba F., Hara M., Takenaka H., Jayawardana S.T., et al. The extra domain A of fibronectin stimulates murine mast cells via toll-like receptor 4. J Leukocyte Biol 2007, 82:657-665.
7. Thompson C., Blumenstock F.A., Saba T.M., Feustel P.J., Kaplan J.E., Fortune J.B., et al. Plasma fibronectin synthesis in normal and injured humans as determined by stable isotope incorporation. J Clin Invest. 1989, 84:1226-1235.
8. Sudhakaran P.R., Radhika A., Jacob S.S. Monocyte macrophage differentiation in vitro: fibronectin-dependent upregulation of certain macrophage-specific activities. Glycoconjugate J 2007, 24:49-55.
9. Ren L., Blanchette J.B., White L.R., Clark S.A., Heffner D.J., Tibbles L.A., et al. Soluble fibronectin induces chemokine gene expression in renal tubular epithelial cells. Kidney Int. 2005, 68:2111-2120.
10. Zardi L., Siri A., Carnemolla B., Santi L., Gardner W.D., Hoch S.O. Fibronectin: a chromatin-associated protein?. Cell 1979, 18:649-657.
11. Pande H., Calaycay J., Hawke D., Ben-Avram C.M., Shively J.E. Primary structure of a glycosylated DNA-binding domain in human plasma fibronectin. J Biol Chem 1985, 260:2301-2306.
12. Hayashi M., Yamada K.M. Differences in domain structures between plasma and cellular fibronectins. J Biol Chem 1981, 256:11292-11300.
13. Akiyama S.K., Yamada K.M., Hayashi M. The structure of fibronectin and its role in cellular adhesion. J Supramol Str Cell Biochem 1981, 16:345-348.
14. Calaycay J., Pande H., Lee T., Borsi L., Siri A., Shively J.E., et al. Primary structure of a DNA- and heparin-binding domain (Domain III) in human plasma fibronectin. J Biol Chem 1985, 260:12136-12141.
15. Hayashi M., Yamada K.M. Divalent cation modulation of fibronectin binding to heparin and to DNA. J Biol Chem 1982, 257:5263-5267.
16. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740-745.
17. Latz E., Schoenemeyer A., Visintin A., Fitzgerald K.A., Monks B.G., Knetter C.F., et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 2004, 5:190-198.
18. Ahmad-Nejad P., Hacker H., Rutz M., Bauer S., Vabulas R.M., Wagner H. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur J Immunol 2002, 32:1958-1968.
19. Leifer C.A., Kennedy M.N., Mazzoni A., Lee C., Kruhlak M.J., Segal D.M. TLR9 is localized in the endoplasmic reticulum prior to stimulation. J Immunol 2004, 173:1179-1183.
20. Yasuda K., Kawano H., Yamane I., Ogawa Y., Yoshinaga T., Nishikawa M., et al. Restricted cytokine production from mouse peritoneal macrophages in culture in spite of extensive uptake of plasmid DNA. Immunology 2004, 111:282-290.
21. Yoshinaga T., Yasuda K., Ogawa Y., Nishikawa M., Takakura Y. DNA and its cationic lipid complexes induce CpG motif-dependent activation of murine dendritic cells. Immunology 2007, 120:295-302.
22. Yoshida H., Nishikawa M., Yasuda S., Mizuno Y., Takakura Y. Cellular activation by plasmid DNA in various macrophages in primary culture. J Pharm Sci 2008, 97:4575-4585.
23. Renshaw M., Rockwell J., Engleman C., Gewirtz A., Katz J., Sambhara S. Cutting edge: impaired Toll-like receptor expression and function in aging. J Immunol 2002, 169:4697-4701.
24. Nomura T., Yasuda K., Yamada T., Okamoto S., Mahato R.I., Watanabe Y., et al. Gene expression and antitumor effects following direct interferon (IFN)-gamma gene transfer with naked plasmid DNA and DC-chol liposome complexes in mice. Gene Ther 1999, 6:121-129.
25. Klinman D.M., Yi A.K., Beaucage S.L., Conover J., Krieg A.M. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. P Natl Acad Sci USA 1996, 93:2879-2883.
26. Sparwasser T., Miethke T., Lipford G., Erdmann A., Hacker H., Heeg K., et al. Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock. Eur J Immunol 1997, 27:1671-1679.
27. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995, 374:546-549.
28. Hacker H., Mischak H., Miethke T., Liptay S., Schmid R., Sparwasser T., et al. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. Embo J 1998, 17:6230-6240.
29. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413:732-738.
30. Takaoka A., Wang Z., Choi M.K., Yanai H., Negishi H., Ban T., et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007, 448:501-505.
31. Wang Z., Choi M.K., Ban T., Yanai H., Negishi H., Lu Y., et al. Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules. P Natl Acad Sci USA 2008, 105:5477-5482.
32. Bortolussi R., Rajaraman K., Qing G., Rajaraman R. Fibronectin enhances in vitro lipopolysaccharide priming of polymorphonuclear leukocytes. Blood 1997, 89:4182-4189.
33. Gruenbaum Y., Stein R., Cedar H., Razin A. Methylation of CpG sequences in eukaryotic DNA. FEBS Lett 1981, 124:67-71.
34. Stacey K.J., Young G.R., Clark F., Sester D.P., Roberts T.L., Naik S., et al. The molecular basis for the lack of immunostimulatory activity of vertebrate DNA. J Immunol 2003, 170:3614-3620.
35. Anders H.J. A Toll for lupus. Lupus 2005, 14:417-422.
36. Roberts T.L., Sweet M.J., Hume D.A., Stacey K.J. Cutting edge: species-specific TLR9-mediated recognition of CpG and non-CpG phosphorothioate-modified oligonucleotides. J Immunol 2005, 174:605-608.
37. Yasuda K., Yu P., Kirschning C.J., Schlatter B., Schmitz F., Heit A., et al. Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways. J Immunol 2005, 174:6129-6136.
38. Yasuda K., Rutz M., Schlatter B., Metzger J., Luppa P.B., Schmitz F., et al. CpG motif-independent activation of TLR9 upon endosomal translocation of " natural" phosphodiester DNA. Eur J Immunol 2006, 36:431-436.
39. Haas T., Metzger J., Schmitz F., Heit A., Muller T., Latz E., et al. The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation. Immunity 2008, 28:315-323.
40. Hajjar A.M., Ernst R.K., Tsai J.H., Wilson C.B., Miller S.I. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol 2002, 3:354-359.
41. Ranjith-Kumar C.T., Duffy K.E., Jordan J.L., Eaton-Bassiri A., Vaughan R., Hoose S.A., et al. Single-stranded oligonucleotides can inhibit cytokine production induced by human toll-like receptor 3. Mol Cell Biol. 2008, 28:4507-4519.